[Update on the treatment of RASopathies].

CONCLUSIONS: Today, thanks to the results from the first studies conducted with MEK inhibitor based mainly on animal models, a number of promising clinical trials are being carried out.
PMID: 28524213 [PubMed - in process]

Source: Revista de Neurologia - May 17, 2017 Category: Neurology Authors: Duat-Rodriguez A, Hernandez-Martin A Tags: Rev Neurol Source Type: research